![Daniel O. Hayden](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel O. Hayden
Keine laufenden Positionen mehr
Karriereverlauf von Daniel O. Hayden
Ehemalige bekannte Positionen von Daniel O. Hayden
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Commonwealth Biotechnologies, Inc.
![]() Commonwealth Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Commonwealth Biotechnologies, Inc. is a life sciences outsourcing company, which offers cutting-edge expertise and a complete array of Peptide-based discovery chemistry and biology products and services through its subsidiary Mimotopes PtyLtd. The company was founded by Richard J. Freer and Robert B. Harris on September 30, 1992 and is headquartered in Midlothian, VA. | Direktor/Vorstandsmitglied | 01.01.2007 | 31.03.2009 |
Commonwealth Biotechnologies, Inc.
![]() Commonwealth Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Commonwealth Biotechnologies, Inc. is a life sciences outsourcing company, which offers cutting-edge expertise and a complete array of Peptide-based discovery chemistry and biology products and services through its subsidiary Mimotopes PtyLtd. The company was founded by Richard J. Freer and Robert B. Harris on September 30, 1992 and is headquartered in Midlothian, VA. | Direktor/Vorstandsmitglied | 29.03.2007 | 30.03.2009 |
Southern Research Institute
![]() Southern Research Institute Miscellaneous Commercial ServicesCommercial Services Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL. | Direktor/Vorstandsmitglied | 10.11.2015 | - |
Genzyme Pharmaceuticals, Inc.
![]() Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 1 |
Sektoral
Commercial Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Commonwealth Biotechnologies, Inc.
![]() Commonwealth Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Commonwealth Biotechnologies, Inc. is a life sciences outsourcing company, which offers cutting-edge expertise and a complete array of Peptide-based discovery chemistry and biology products and services through its subsidiary Mimotopes PtyLtd. The company was founded by Richard J. Freer and Robert B. Harris on September 30, 1992 and is headquartered in Midlothian, VA. | Commercial Services |
Genzyme Pharmaceuticals, Inc.
![]() Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. The company is headquartered in Cambridge, MA. | Health Technology |
Southern Research Institute
![]() Southern Research Institute Miscellaneous Commercial ServicesCommercial Services Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL. | Commercial Services |
- Börse
- Insiders
- Daniel O. Hayden
- Erfahrung